Hemispherx Biopharma makes progress with Phase 2 clinical trial to treat ovarian cancer
Hemispherx Biopharma Inc (NYSEAMERICAN:HEB) CEO Thomas Equels tells Proactive Investors the biopharma has taken a key step forward in its Phase 2 clinical trial after it announced that the first patient has been treated with its flagship drug Ampligen.
Equels says this study looks at the effectiveness of Ampligen in combination with the drug Pembrolizumab at treating ovarian cancer.
Story by ProactiveInvestors
Order by Phone at 888-809-8385 or online at www.mitocopper.com
Get our Free Ebook, "Suppressed Health Secrets" THEY don't want you to know!
APeX - Far superior to colloidal silver! Desroys Viruses, Bacteria, Pathogens!
Ultimate Curcumin - Natural pain relief, reduce inflammation and so much more.
Supreme Fulvic - Nature's most important supplement! Vivid Dreams again!
MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy.
Oxy Powder - Natural Colon Cleanser! Cleans out toxic buildup!
B-12 - Supports healthy metabolism, brain function, hormone balance!
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Never Wax Your Car Again - Protects vehicles for years with dazzling shine!
Smart Meter Cover - Reduces Smart Meter radiation! See Video!
Prodovite - The Secret To Healing is in the Blood!
|New Laser Blinds Attackers Instantly!||Bring
|NASA - US Faces 100 Year Drought!||Discovery
Bills by 65%